NCT04165629View on ClinicalTrials.gov

Platelet Reactivity in PAD Undergoing Percutaneous Angioplasty

UnknownOBSERVATIONAL
Enrollment

450

Participants

Timeline

Start Date

January 1, 2020

Primary Completion Date

January 1, 2022

Study Completion Date

July 1, 2022

Conditions
Peripheral Artery DiseaseCritical Limb IschemiaClaudication, Intermittent
Interventions
DRUG

Aspirin 300mg and Clopidogrel 300mg

Aspirin 300mg and Clopidogrel 300mg on the day of the PTA

Trial Locations (1)

11000

RECRUITING

Clinical Center of Serbia, Belgrade

Sponsors
All Listed Sponsors
lead

Clinical Centre of Serbia

OTHER